Last week new diagnostic tests prices were launched. Our patients can now get their tests at a lower price. This is the result of increased interest in molecular research that allows for the economies of scale.

As a part of the coronavirus sequencing project, more records were added to the GISAID database, including the second case of the British variant confirmed by us. Currently, we have deposited 246 SARS-CoV-2 genomes, which is 44% of the Polish committed records.